Table 2.
Questionnaire Responses by HIV Infection Status
| Instrument | HIV Negative (N = 176) | HIV Positive (N = 63) | p-value |
|---|---|---|---|
| Median (IQR) | |||
| SSSS (range: 0–4) | |||
| Partner | |||
| Emotional Support | 3.8 (3.0–4.0) | 3.7 (2.8–4.0) | 0.81 |
| Negative Support | 4.0 (4.0–4.0) | 4.0 (4.0–4.0) | 0.28 |
| Informational Support | 2.5 (0.0–4.0) | 2.0 (0.0–4.0) | 0.55 |
| Instrumental Support | 4.0 (2.0–4.0) | 4.0 (1.0–4.0) | 0.49 |
| Women in Your Family | |||
| Emotional Support | 4.0 (3.3–4.0) | 4.0 (3.7–4.0) | 0.11 |
| Negative Support | 4.0 (4.0–4.0) | 4.0 (4.0–4.0) | 0.31 |
| Informational Support | 4.0 (2.0–4.0) | 4.0 (2.0–4.0) | 0.59 |
| Instrumental Support | 4.0 (2.0–4.0) | 4.0 (2.0–4.0) | 0.26 |
| Friends | |||
| Emotional Support | 4.0 (3.3–4.0) | 3.7 (3.3–4.0) | 0.26 |
| Negative Support | 4.0 (4.0–4.0) | 4.0 (4.0–4.0) | 0.03 |
| Informational Support | 4.0 (2.0–4.0) | 3.0 (1.0–4.0) | 0.22 |
| Instrumental Support | 4.0 (2.0–4.0) | 3.0 (1.0–4.0) | 0.21 |
| Healthcare Provider | |||
| Emotional Support | 4.0 (3.5–4.0) | 4.0 (4.0–4.0) | 0.02 |
| Negative Support | 4.0 (4.0–4.0) | 4.0 (4.0–4.0) | 0.97 |
| Informational Support | 4.0 (4.0–4.0) | 4.0 (4.0–4.0) | 0.07 |
| Instrumental Support | 4.0 (4.0–4.0) | 4.0 (4.0–4.0) | 0.86 |
| HELT-LL | |||
| Functional Literacy (range: 0–14) | 9.0 (7.0–11.0) | 9.0 (6.0–11.0) | 0.70 |
| Communicative Literacy (range: 0–4) | 2.0 (1.0–3.0) | 2.0 (1.0–4.0) | 0.92 |
| Critical Literacy (range: 0–6) | 4.0 (2.0–4.0) | 4.0 (2.0–6.0) | 0.31 |
| BMQ | |||
| AET Concerns (range: 0–20) | 4.0 (0.0–8.0) | 5.0 (0.0–9.0) | 0.39 |
| AET Necessity (range: 0–20) | 18.0 (15.0–20.0) | 17.0 (16.0–20.0) | 0.82 |
| General Overuse (range: 0–16) | 7.0 (4.0–10.0) | 8.0 (4.0–10.0) | 0.52 |
| General Harms (range: 0–16) | 2.0 (0.0–5.0) | 3.0 (0.0–5.0) | 0.73 |
| CASE-Cancer | |||
| Participation in Care (range: 4–16) | 16.0 (14.0–16.0) | 16.0 (16.0–16.0) | 0.02 |
| Positive Attitude (range: 4–16) | 16.0 (15.0–16.0) | 16.0 (16.0–16.0) | 0.08 |
| Seeking Information (range: 4–16) | 16.0 (15.0–16.0) | 16.0 (16.0–16.0) | 0.07 |
| Mental Health Questionnaires (Mean score) | |||
| CES-D (range: 0–60) | 15.5 (8.0–23.0) | 17.0 (10.5–27.0) | 0.16 |
| GAD-7 (range: 0–21) | 5.0 (2.0–9.0) | 7.0 (3.0–11.0) | 0.11 |
| PSS (range: 0–40) | 16.0 (12.0–21.0) | 17.5 (13.0–23.0) | 0.29 |
| AET-Related Side Effect Scores | |||
| Cognitive (range: 0–12) | 4.0 (1.5–6.5) | 4.0 (1.5–6.5) | 0.62 |
| Musculoskeletal (range: 0–12) | 5.0 (2.5–8.0) | 5.0 (2.5–8.0) | 0.96 |
| Vasomotor (range: 0–12) | 2.0 (0.5–6.0) | 5.0 (1.5–8.0) | 0.01 |
| Gastrointestinal (range: 0–12) | 0.0 (0.0–0.5) | 0.0 (0.0–1.0) | 0.15 |
| Dyspareunia (range: 0–8) | 0.0 (0.0–1.0) | 0.5 (0.0–1.5) | 0.12 |
| Weight Control (range: 0–8) | 1.0 (0.0–3.0) | 2.0 (1.0–3.5) | 0.02 |
| Gynecologic (range: 0–12) | 0.5 (0.0–1.0) | 0.5 (0.0–2.0) | 0.34 |
| Urinary incontinence (range: 0–8) | 0.0 (0.0–1.3) | 0.0 (0.0–1.0) | 0.39 |
| Pain/Fatigue (range: 0–36) | 8.8 (5.0–13.0) | 10.0 (6.0–13.0) | 0.32 |
Abbreviations: AET – adjuvant endocrine therapy; BMQ – Beliefs About Medication Questionnaire; CASE-Cancer – Communication and Attitudinal Self-Efficacy scale; CES-D – Center for Epidemiological Studies Depression Scale; GAD-7 – Generalized Anxiety Disorder 7-Item Scale; HELT-LL – Health Literacy Test for Limited Literacy populations; PSS – Perceived Stress Scale; SSSS –Sources of Social Support Scale